Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing of blood components, as well as in transfusion medicine. The Fresenius Helios segment operates 86 hospitals, 124 outpatient clinics, and 10 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company has a strategic partnership with Vifor Pharma Group. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany. Show More...
-
Website http://www.fresenius.com
-
Sector Healthcare
-
Industry Medical Care Facilities
-
Last Quote 0.19 EUR
-
Last Updated 28-03-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 1.26 1.39 1.76 1.87 1.96 2.48 2.83 3.25 3.63 3.38 3.39 Dividends EUR 0.75 0.86 0.95 1.1 1.25 0.44 0.55 0.62 0.75 0.8 0.8 Payout Ratio % * 19.9 19.3 20.7 23.7 23.6 Shares Mil 488.0 493.0 524.0 540.0 544.0 548.0 550.0 558.0 557.0 557.0 558.0 Book Value Per Share * EUR 21.46 23.83 26.64 29.91 30.82 Free Cash Flow Per Share * EUR 3.32 4.38 2.6 3.25 Return on Assets % 2.8 2.77 3.25 3.19 2.94 3.27 3.56 3.64 3.69 3.04 2.82 Financial Leverage (Average) 4.75 4.41 4.02 4.0 4.27 3.95 3.71 3.89 3.68 3.99 4.01 Return on Equity % 13.47 12.62 13.61 12.77 12.17 13.4 13.59 13.87 13.94 11.7 11.39 Return on Invested Capital % 8.25 8.02 9.17 7.21 6.54 7.08 7.57 7.7 7.42 6.21 4.29 Interest Coverage 4.0 4.29 4.32 4.8 4.44 4.76 6.52 5.64 5.95 5.44 Current Ratio 1.13 1.19 1.56 1.32 1.41 1.47 1.38 1.18 1.11 1.1 1.02 Quick Ratio 0.65 0.65 0.92 0.77 0.84 0.85 0.85 0.76 0.77 0.72 0.61 Debt/Equity 1.47 0.67 1.35 1.34 1.48 1.24 1.03 1.18 0.91 1.3 1.23